Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
CHANGE
CHANGE Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
1 other identifier
interventional
30
1 country
1
Brief Summary
Surgery is one of the management options for type 2 diabetes in patients with moderate obesity. This is a recent option because it has been part of the recommendations since October 2022. The possible surgical techniques are the same as those for bariatric surgery:
- Sleeve,
- Bypass,
- Gastric band, but the main goal is not weight loss, it is remission of type 2 diabetes. It is called metabolic surgery. The ring technique (gastroplasty) is practiced less and less in France because it is less effective in weight loss and is responsible for major discomfort. Currently, metabolic surgery is one of the recommendations but no study has compared the effectiveness of the techniques with each other. One or other of the techniques can be chosen according to the preferences of the surgeon, the patient, the center, etc. but this choice is not made objectively, in the absence of comparative data. This study would like to follow up on patients for whom metabolic surgery has been proposed by the doctor,. If the surgery is accepted, this study would like to improve knowledge of the effectiveness of the different techniques, and thus demonstrate which metabolic surgery technique is preferred in terms of effectiveness and safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Jul 2024
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2024
CompletedFirst Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2032
September 19, 2024
September 1, 2024
8.4 years
September 9, 2024
September 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
T2DM remission rate
HbA1c lower than 6.5% in the absence of antidiabetic treatment, partial, complete, prolonged remission or no remission between the 2 surgical techniques
1 year after surgery
Study Arms (2)
metabolic surgery with SLEEVE technique
EXPERIMENTALmetabolic surgery with BY-PASS technique
EXPERIMENTALInterventions
metabolic surgery with SLEEVE technique
metabolic surgery with BY-PASS technique
Eligibility Criteria
You may qualify if:
- adult patient and ≤ 65 years old
- T2D patient, with individualized glycemic objectives not achieved, despite medical care, in particular diabetological and nutritional, also including adapted physical activity, well conducted according to current good practice recommendations, for at least twelve months
- BMI between 30 and 34.9 kg/m²
- patient well informed beforehand about metabolic surgery and the study
- medical assessment of an acceptable surgical risk
- patient affiliated to or beneficiary of a social security system
- patient having freely signed the written informed consent
You may not qualify if:
- severe cognitive or mental disorders
- severe and unstabilized eating behavior disorders
- dependence on alcohol and licit and illicit psychoactive substances
- illnesses endangering life in the short and medium term
- contraindications to general anesthesia
- absence of identified prior medical care and foreseeable inability of the patient to participate in lifelong medical monitoring
- history of bariatric surgery
- pregnant or breastfeeding woman, or having a very long-term pregnancy plan short term (\< 2 years)
- adult patient under guardianship or curatorship
- patient deprived of liberty or under judicial decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medipole Lyon Villeurbanne
Villeurbanne, 69100, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 19, 2024
Study Start
July 3, 2024
Primary Completion (Estimated)
December 1, 2032
Study Completion (Estimated)
December 1, 2032
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share